Romark Laboratories L.c. - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsRomark Laboratories L.c.

Romark Laboratories L.c.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Alinia	Nitazoxanide	2004-07-21		Diarrhea , Giardiasis , Cryptosporidiosis , Protozoan infections

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

hepatic insufficiency

,

kidney diseases

,

renal insufficiency

,

retinal diseases

,

liver cirrhosis

,

,

,

,

chronic hepatitis b

,

,

,

viral pneumonia

,

,

non-alcoholic fatty liver disease

,

,

alcoholic fatty liver

,

ulcerative colitis

,

,

,

protozoan infections

,

,

,

,

,

clostridioides difficile

,

,

,

diabetes mellitus

,

,

cryptosporidiosis

,

severe acute respiratory syndrome

,

human influenza

,

,

hepatic encephalopathy

,

,

,

gastroenteritis

,

rotavirus infections

,

,

,

,

,

enterovirus infections

,

,

clostridium infections

,

,

amebic dysentery

,

pseudomembranous enterocolitis

,

,

growth disorders

,

cognitive science

,

,

,

,

adenoviridae infections

,

caliciviridae infections

,

,

rheumatoid arthritis

,

,

sexually transmitted diseases

,

,

cognitive dysfunction

,

colorectal neoplasms

,

,

,

,

,

,

chronic hepatitis c

,

communicable diseases

,

chronic hepatitis

,

coronavirus infections

,

helicobacter infections

,

,

type 2 diabetes mellitus

,

irritable bowel syndrome

,

,

,

,

nutrition disorders

,

child nutrition disorders

,

,

drug interactions

,

muscle spasticity

,

,

microsporidiosis

healthy volunteers/patients

,

renal cell carcinoma

,

,

muscular atrophy

,

spinal muscular atrophy

,

,

,

uterine cervical neoplasms

,

,

chronic hepatitis d

,

,

rheumatoid arthritis

,

,

,

,

,

chronic hepatitis c

,

chronic hepatitis

Albinterferon alfa-2b

,

,

,

chronic hepatitis c

,

,

chronic hepatitis b

,

chronic hepatitis

,

,

chronic hepatitis b

,

,

chronic hepatitis

,

healthy volunteers/patients

,

rheumatoid arthritis

,

,

,

respiratory syncytial viruses

,

human influenza

,

pneumococcal infections

,

pneumococcal pneumonia

,

streptococcus pneumoniae

,

coronavirus infections

,

h1n1 subtype influenza a virus

influenza in birds

,

,

multiple sclerosis

,

,

,

,

,

orthomyxoviridae

,

,

communicable diseases

,

infectious myxomatosis

,

h1n1 subtype influenza a virus

,

,

,

,

,

viral hemorrhagic fevers

,

,

,

,

,

,

,

meningococcal infections

,

,

haemophilus influenzae type b

,

inactivated vaccines

,

,

human influenza

,

orthomyxoviridae infections

,

healthy volunteers/patients

,

,

,

myocardial infarction

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

,

immune system diseases

,

pregnancy complications

,

,

toxicological phenomena

,

,

respiratory syncytial virus infections

,

,

,

,

atrial fibrillation

,

cardiovascular diseases

,

coronary disease

,

cardiac arrhythmias

,

,

,

diabetes mellitus

,

respiratory tract infections

,

inferior wall myocardial infarction

,

severe acute respiratory syndrome

,

behavior and behavior mechanisms

,

human influenza

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use